RESUMEN
BACKGROUND: Women and girls are relatively under-represented across the HIV treatment cascade. Two conditions unique to women, pregnancy and cervical cancer/dysplasia, share a common acquisition mode with HIV. This scoping review aimed to explore HIV testing practices in voluntary termination of pregnancy (TOP) and colposcopy services. METHODS: The scoping review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. We searched articles published up to 20 December 2020 using three electronic databases (PubMed/Medline, Embase, Google Scholar) and including the keywords "HIV Testing", "Abortion, Induced", "Colposcopy", "HIV screen*" and "termination of pregnancy". RESULTS: A total of 1496 articles were identified, of which 55 met the inclusion criteria. We included studies providing background HIV prevalence in addition to prevalence in the study population and studies of women seeking TOP rather than presenting with TOP complications. This limited our review to high-income, low HIV prevalence settings. We observed two study phases: studies pre-antiretroviral therapy (ART) using unlinked anonymous testing data and examining HIV risk factors associated with positive HIV tests and studies post-ART using routine testing data and exploring HIV testing uptake. HIV prevalence was estimated at >0.2% in most TOP settings and >1% (range 1.7%-11.4%) in colposcopy services. Many TOP providers did not have local HIV testing policies and HIV testing was not mentioned in many specialist guidelines. Testing uptake was 49%-96% in TOP and 23%-75% in colposcopy services. CONCLUSION: Given the estimated HIV prevalence of >0.1% among women attending TOP and colposcopy services, HIV testing would be economically feasible to perform in high-income settings. Explicit testing policies are frequently lacking in these two settings, both at the local level and in specialist guidelines. Offering HIV testing regardless of risk factors could normalise testing, reduce late HIV presentation and create an opportunity for preventive counselling.
Asunto(s)
Aborto Inducido , Colposcopía/métodos , Infecciones por VIH/diagnóstico , Prueba de VIH/normas , Tamizaje Masivo/métodos , Colposcopía/estadística & datos numéricos , Femenino , Prueba de VIH/métodos , Humanos , Tamizaje Masivo/normas , EmbarazoRESUMEN
Allogeneic islet of Langerhans transplantation is a recognized beta-cell replacement therapy for patients affected by type 1 diabetes mellitus. Type 1 diabetes mellitus is a condition associated with an increased risk of adverse outcomes for pregnant women and fetuses. We report the case of a 29-year-old woman with type 1 diabetes mellitus, who underwent successful allogeneic islet transplantation with simultaneous kidney transplantation. She achieved durable insulin independence after 2 islet infusions. Pregnancy was desired and planned 2 years after the last islet infusion. Multidisciplinary monitoring of pregnancy was carried out and the immunosuppressive regimen was adapted. Euglycemia was maintained throughout pregnancy without the need for exogenous insulin. After an uneventful pregnancy, she delivered on term an otherwise healthy male child with imperforate anus that was immediately surgically corrected. In conclusion, allogeneic islet transplantation is a suitable treatment for women of childbearing age with complicated type 1 diabetes mellitus, allowing physiologic glycemic control during pregnancy with a low risk of graft loss. This target can be achieved only by a tight multidisciplinary follow-up, including immunosuppressive therapy adaptation and adequate diabetes and obstetrical monitoring.
Asunto(s)
Diabetes Mellitus Tipo 1/terapia , Trasplante de Islotes Pancreáticos/métodos , Trasplante de Riñón/métodos , Trabajo de Parto , Complicaciones del Embarazo/prevención & control , Adulto , Femenino , Humanos , Embarazo , Resultado del EmbarazoAsunto(s)
Fármacos Anti-VIH/farmacocinética , Cobicistat/sangre , Cobicistat/farmacocinética , Infecciones por VIH/sangre , Periodo Posparto/sangre , Quinolonas/sangre , Quinolonas/farmacocinética , Adulto , Fármacos Anti-VIH/sangre , Combinación Elvitegravir, Cobicistat, Emtricitabina y Fumarato de Tenofovir Disoproxil/sangre , Combinación Elvitegravir, Cobicistat, Emtricitabina y Fumarato de Tenofovir Disoproxil/farmacocinética , Femenino , Humanos , EmbarazoRESUMEN
Prenatal diagnosis of congenital lung anomalies has increased in recent years as imaging methods have benefitted from technical improvements. The purpose of this pictorial essay is to illustrate typical imaging findings of a wide spectrum of congenital lung anomalies on prenatal US and MRI. Moreover, we propose an algorithm based on imaging findings to facilitate the differential diagnosis, and suggest a follow-up algorithm during pregnancy and in the immediate postnatal period.
Asunto(s)
Algoritmos , Interpretación de Imagen Asistida por Computador/métodos , Pulmón/anomalías , Diagnóstico Prenatal/métodos , Anomalías del Sistema Respiratorio/diagnóstico , Ultrasonografía/métodos , Humanos , Pulmón/diagnóstico por imagen , Pulmón/patología , Imagen por Resonancia MagnéticaRESUMEN
Cardiac defects form the most frequently encountered group of congenital malformations (0.8%). Despite the improving ultrasonographic technology and the teaching of the investigators, the prenatal recognition of cardiac defects stays low (around 30%). The application of 3D technology in their recognition may well lead to a substantial improvement of this percentage. This technique consists of a consecutive summation of multiple 2D images and permits the three dimensional reconstruction of the different structures and the definition of their spatial position. Its importance is localised in the direct identification of normal anatomy and the possibility to reevaluate the data in an off-line version and if necessary to ask for a specialised second opinion on the same data set, thus opening the door for telemedical approach.
Asunto(s)
Cardiopatías Congénitas/diagnóstico por imagen , Cardiopatías Congénitas/embriología , Imagenología Tridimensional , Ultrasonografía Prenatal , Femenino , Humanos , EmbarazoRESUMEN
PRINCIPLES: Interstitial pregnancy represents 2% of ectopic pregnancies, but it is a highly morbid condition with a 2.5% of maternal mortality. Its diagnostic and therapeutic management remains controversial. The aim of this review is to describe the management of interstitial pregnancy in our institution between 2001 and 2011 and to define some general rules for the clinical practice. METHODS: Single institution retrospective study. RESULTS: Eleven women were treated for interstitial pregnancy. The median age was 33 years and the median gestity was 4. Seven patients had a history of gynaecological surgery and four interstitial pregnancies followed in vitro fertilisation. The diagnosis was made at a median gestational age of seven weeks with a median beta-HCG level of 5,838 U/l. Six of the eleven patients received an initial treatment with intracornual methotrexate, three with intramuscular methotrexate and two with surgery. The median time to beta-HCG resolution was 58 days. Three of the eleven patients needed a second line treatment: two after intramuscular methotrexate and one after intracornual methotrexate. Six patients had further pregnancies and delivered by caesarean section. CONCLUSIONS: A high prevalence of previous ectopic pregnancies, gynaecological surgery and of pregnancies resulting from in vitro fertilisation was observed. The earliness of the diagnosis was the factor that allowed a conservative treatment in most cases. Beta-HCG level follow up was fundamental in allowing a second line therapy but beta-HCG can persist over a long period of time and this must be taken into account due to its possible psychological impact. Intracornual methotrexate seems to be more efficacious than intramuscular methotrexate in our series.
Asunto(s)
Metotrexato/uso terapéutico , Embarazo Ectópico/tratamiento farmacológico , Embarazo Ectópico/cirugía , Adulto , Gonadotropina Coriónica Humana de Subunidad beta/sangre , Femenino , Fertilización In Vitro , Edad Gestacional , Humanos , Embarazo , Embarazo Ectópico/diagnóstico , Estudios RetrospectivosRESUMEN
We report the case of an asymptomatic neonate prenatally diagnosed with a left basal pulmonary sequestration. The preoperative chest computed tomography with contrast showed 2 aberrant arteries arising from the distal thoracic aorta and supplying the intralobar left inferior lung malformation. Strategy and treatment by thoracoscopic segmentectomy are presented.